Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.
Rational Vaccines has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in October 2023.
Rational Vaccines's investors include Founders Fund, AAF Management Ltd., Presight Capital, National Institutes of Health, Thiel Capital.
Rational Vaccines is headquartered in Woburn, United States.
Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.
Rational Vaccines is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rational Vaccines — Funding & Investors." VCBacked, October 13, 2023, https://www.vcbacked.co/company/rational-vaccines. Accessed July 20, 2026.
VCBacked. (2023). Rational Vaccines — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/rational-vaccines
{{cite web |title=Rational Vaccines — Funding & Investors |url=https://www.vcbacked.co/company/rational-vaccines |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated